BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24931151)

  • 1. [Study on the clinical manifestation of 90 cases with scleritis and episcleritis].
    Zhou Y; Wang Z; Zhang Y; Sun X
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):261-6. PubMed ID: 24931151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center.
    Berchicci L; Miserocchi E; Di Nicola M; La Spina C; Bandello F; Modorati G
    Eur J Ophthalmol; 2014; 24(3):293-8. PubMed ID: 24242216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of scleritis and episcleritis.
    Sainz de la Maza M; Jabbur NS; Foster CS
    Ophthalmology; 1994 Feb; 101(2):389-96. PubMed ID: 8115160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and response to systemic treatment of primary and secondary episcleritis and scleritis resistant to local treatment].
    Cuchacovich T M; Pacheco P; Merino G; Gallardo P; Gatica H; Valenzuela H; Verdaguer J; Verdaguer J
    Rev Med Chil; 2000 Nov; 128(11):1205-14. PubMed ID: 11347507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the clinical manifestation of 438 cases with blepharitis].
    Sun XG; Zhou YM; Jiang C; Wang ZQ; Zhang Y
    Zhonghua Yan Ke Za Zhi; 2013 Oct; 49(10):878-83. PubMed ID: 24433688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of episcleritis and scleritis in Northern California.
    Honik G; Wong IG; Gritz DC
    Cornea; 2013 Dec; 32(12):1562-6. PubMed ID: 24145628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases.
    Gonzalez-Gonzalez LA; Molina-Prat N; Doctor P; Tauber J; Sainz de la Maza MT; Foster CS
    Ophthalmology; 2012 Jul; 119(7):1460-4. PubMed ID: 22463821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cogan I syndrome: clinical aspects, therapy and prognosis].
    Zierhut M; Schlote T; Stübiger N; Daikeler T; Kötter I; Bless D; Koitschev A
    Ophthalmologe; 2000 Mar; 97(3):197-202. PubMed ID: 10789178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era.
    Caimmi C; Crowson CS; Smith WM; Matteson EL; Makol A
    J Rheumatol; 2018 May; 45(5):595-603. PubMed ID: 29449499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of episcleritis and systemic disease association.
    Akpek EK; Uy HS; Christen W; Gurdal C; Foster CS
    Ophthalmology; 1999 Apr; 106(4):729-31. PubMed ID: 10201593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indication and effect of immunosuppression in patients with scleritis].
    Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of scleritis in patients older than 60 years].
    Sainz De La Maza Serra M; Escobar Barranco JL; Foster CS
    Arch Soc Esp Oftalmol; 2001 Jul; 76(7):425-30. PubMed ID: 11438879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy.
    Sainz de la Maza M; Foster CS; Jabbur NS; Baltatzis S
    Arch Ophthalmol; 2002 Jan; 120(1):15-9. PubMed ID: 11786052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New clinical and epidemiologic aspects of episcleritis and scleritis].
    Denk PO; Rohrbach JM; Thiel HJ; Zierhut M
    Ophthalmologe; 1997 Mar; 94(3):202-5. PubMed ID: 9181836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of episcleritis and scleritis in urban Australia.
    Thong LP; Rogers SL; Hart CT; Hall AJ; Lim LL
    Clin Exp Ophthalmol; 2020 Aug; 48(6):757-766. PubMed ID: 32279425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episcleritis and scleritis: clinical features and treatment results.
    Jabs DA; Mudun A; Dunn JP; Marsh MJ
    Am J Ophthalmol; 2000 Oct; 130(4):469-76. PubMed ID: 11024419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular scleritis, episcleritis and anterior uveitis as ocular complications of Crohn's disease.
    Schuettenberg SP
    J Am Optom Assoc; 1991 May; 62(5):377-81. PubMed ID: 1813533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.